Medical News

RSS

Scientists develop potential new treatment against ovarian cancer

Scientists at Georgia Tech and the Ovarian Cancer Institute have further developed a potential new treatment against cancer that uses magnetic nanoparticles to attach to cancer cells, removing them from the body.

2 Feb 2010

Tips to ease prenatal back and neck pain from LSI

One of the most common discomforts experienced by women during pregnancy is back pain. Expectant mothers endure a variety of different types of backache as their hormones and posture change during pregnancy.

2 Feb 2010

Mouse model demonstrates cell-to-cell connections between implanted stem cells and diseased cells

Investigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham, formerly Burnham Institute for Medical Research), the Karolinska Institutet, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School and Universit- Libre de Bruxelles have demonstrated in mouse models that transplanted stems cells, when in direct contact with diseased neurons, send signals through specialized channels that rescue the neurons from death.

2 Feb 2010

GMC designated as NMDP collection site to collect bone marrow from willing donors

Geisinger Medical Center (GMC) was recently designated a National Marrow Donation Program (NMDP) collection site, becoming the only site in the region to collect bone marrow or blood stem cells from willing donors.

2 Feb 2010

CCA launches 2010 Excellence Awards Programme to recognise phenomenal change in customer service

CCA Excellence Awards is the most respected and sought-after programme, unique through its peer group judging process. The judging panel includes professionals from all sectors and senior executives with wide-ranging experience in customer contact.

2 Feb 2010

Professional Products unveils Shoulder Stabilizing Orthosis for athletes

The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.

2 Feb 2010

Decision Resources: Benlysta to garner more than $500M in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected regulatory approval in 2011 in the United States and Europe, Human Genome Sciences/GlaxoSmithKline's Benlysta will garner sales of more than $500 million in 2018 in the systemic lupus erythematosus drug market.

2 Feb 2010

Nursing jobs no longer recession-proof

"A few years ago, hospitals were offering nurses $10,000 signing bonuses, loan payoffs, even cars as incentives to battle a nursing shortage in Texas. Today, some nursing school graduates say they're fortunate to find a job," The Star-Telegram reports. "Three years ago there were three job offers for every graduate, said Dr. Pamela Frable, director of nursing at Texas Christian University's Harris College of Nursing and Health Sciences. But at graduation last summer, there were more students without a job than ever before.

2 Feb 2010

Boston Scientific to pay J&J $1.725 billion for settling three patent disputes

Boston Scientific Corporation today announced the settlement of three patent disputes with Johnson & Johnson (J&J). The disputes date back to 2003 and cover Boston Scientific's Jang patent and J&J's Palmaz and Gray patents, all of which involve intellectual property in the cardiovascular arena. Boston Scientific will make a $1.725 billion payment to J&J in connection with the settlement.

2 Feb 2010

Danaher acquires Life Technologies' mass spectrometry business

Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.

From Danaher 2 Feb 2010

Some states mull requiring prescription for meth ingredients

"State and local efforts to thwart methamphetamine production by further limiting consumer access to a popular decongestant are pitting law enforcement against pharmacists and patients," USA Today reports.

2 Feb 2010

Companies may hit new anti-discrimination law when asking workers about health issues

Employers offering wellness and preventive health programs can sometimes run afoul of a new anti-discrimination law restricting their ability to ask workers about family medical histories, The Wall Street Journal reports.

2 Feb 2010

NYBC urges people to donate blood

New York Blood Center (NYBC), serving New York City, Long Island, the Hudson Valley, and New Jersey, calls upon people of diverse backgrounds to please donate blood. The need for blood is constant.

2 Feb 2010

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Phosphagenics Limited today announced positive results from a Phase 1B clinical study using the Company’s patented TPM™ (Targeted Penetration Matrix) for the transdermal delivery of oxycodone. The results of the successful trial demonstrate that daily application of a TPM™ patch delivers therapeutic levels of oxycodone into the blood stream in a reproducible, consistent and sustained manner.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

FDA and PATH collaborate to advance pneumococcal vaccine development for children

The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia.

2 Feb 2010

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

Response Biomedical Corporation announced that the Company has signed a second partner, Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China to sell the Company’s diagnostic products, expanding its strategic presence in this important global market.

2 Feb 2010

IMRT and extensive safety measures can prevent radiation injuries in cancer patients, says oncology expert

Recent media stories have reported isolated cases of cancer patients who were injured by incorrect doses from intensity-modulated radiation therapy (IMRT).

2 Feb 2010

Memory loss or decline in thinking abilities may indicate higher risk of stroke

People who experience memory loss or a decline in their thinking abilities may be at higher risk of stroke, regardless of whether they have been diagnosed with dementia, according to a new study published in the February 2, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Feb 2010

Long-chain omega-3 polyunsaturated fatty acids may reduce risk of psychotic disorders

Individuals at extremely high risk of developing psychosis appear less likely to develop psychotic disorders following a 12-week course of fish oil capsules containing long-chain omega-3 polyunsaturated fatty acids, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

Medical News

Scientists develop potential new treatment against ovarian cancer

Tips to ease prenatal back and neck pain from LSI

Mouse model demonstrates cell-to-cell connections between implanted stem cells and diseased cells

GMC designated as NMDP collection site to collect bone marrow from willing donors

CCA launches 2010 Excellence Awards Programme to recognise phenomenal change in customer service

Professional Products unveils Shoulder Stabilizing Orthosis for athletes

Decision Resources: Benlysta to garner more than $500M in 2018

Nursing jobs no longer recession-proof

Boston Scientific to pay J&J $1.725 billion for settling three patent disputes

Danaher acquires Life Technologies' mass spectrometry business

Some states mull requiring prescription for meth ingredients

Companies may hit new anti-discrimination law when asking workers about health issues

NYBC urges people to donate blood

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

FDA and PATH collaborate to advance pneumococcal vaccine development for children

Response Biomedical continues global market expansion, signs Guangzhou Wondfo Biotech in China

IMRT and extensive safety measures can prevent radiation injuries in cancer patients, says oncology expert

Memory loss or decline in thinking abilities may indicate higher risk of stroke

Long-chain omega-3 polyunsaturated fatty acids may reduce risk of psychotic disorders

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News